Skip to main content
Top
Published in: Surgery Today 1/2014

01-01-2014 | Review Article

Preoperative liver function assessments to estimate the prognosis and safety of liver resections

Authors: Toru Mizuguchi, Masaki Kawamoto, Makoto Meguro, Thomas T. Hui, Koichi Hirata

Published in: Surgery Today | Issue 1/2014

Login to get access

Abstract

Liver function assessment is important to ensure safe surgical procedures in patients with hepatocellular disease. Because the liver influences a wide variety of functions, including protein synthesis and metabolic, immune and storage functions, no single parameter is sufficient to adequately address all of these functions. We reviewed the relevant literature concerning the scoring systems, functional tests, plasma parameters and imaging modalities currently used to evaluate the liver function in an attempt to determine which parameters provide the most comprehensive and useful results. While the Child–Pugh scoring system is the gold standard for liver disease assessment, the liver damage grading system recommended by the Liver Cancer Study Group of Japan is also useful. Various models for end-stage liver disease scoring are used for organ allocation. While the indocyanine green clearance test is widely accepted throughout the world, other assessments have not been used routinely for clinical evaluations. The levels of plasma proteins, including albumin, prealbumin, retinol binding protein, apolipoprotein, coagulation factors and antithrombin III, represent the liver productivity. Liver fibrotic markers also correlate with liver function. Imaging modalities such as 99mTc-galactosyl serum albumin scintigraphy, 99mTc-mebrofenin hepatobiliary scintigraphy and transient elastography are also available, but future studies are needed to validate their clinical efficacy.
Literature
1.
go back to reference Chow PK. Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria? J Gastroenterol Hepatol. 2012;27:452–7.PubMedCrossRef Chow PK. Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria? J Gastroenterol Hepatol. 2012;27:452–7.PubMedCrossRef
2.
go back to reference Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, et al. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2012 [Epub ahead of print]. doi:10.1097/SLA.0b013e31825d5d47. Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, et al. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2012 [Epub ahead of print]. doi:10.​1097/​SLA.​0b013e31825d5d47​.
3.
5.
go back to reference Yamamoto M, Ariizumi S. Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today. 2011;41:896–902.PubMedCrossRef Yamamoto M, Ariizumi S. Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today. 2011;41:896–902.PubMedCrossRef
6.
go back to reference Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85.PubMed Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1–85.PubMed
7.
go back to reference Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.PubMedCrossRef Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–9.PubMedCrossRef
8.
go back to reference Nakamura Y, Mizuguchi T, Kawamoto M, Meguro M, Harada K, Ota S, et al. Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy. Surgery. 2011;150:250–62.PubMedCrossRef Nakamura Y, Mizuguchi T, Kawamoto M, Meguro M, Harada K, Ota S, et al. Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy. Surgery. 2011;150:250–62.PubMedCrossRef
9.
go back to reference Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41:1211–9.PubMedCrossRef Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41:1211–9.PubMedCrossRef
10.
go back to reference Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, et al. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol. 2000;35:659–64.PubMedCrossRef Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, et al. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol. 2000;35:659–64.PubMedCrossRef
11.
go back to reference Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis. 2006;10:665–678, x–xi. Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis. 2006;10:665–678, x–xi.
12.
go back to reference Omagari K, Ohba K, Kadokawa Y, Hazama H, Masuda J, Kinoshita H, et al. Comparison of the grade evaluated by “Liver damage” of Liver Cancer Study Group of Japan and Child–Pugh classification in patients with hepatocellular carcinoma. Hepatol Res. 2006;34:266–72.PubMedCrossRef Omagari K, Ohba K, Kadokawa Y, Hazama H, Masuda J, Kinoshita H, et al. Comparison of the grade evaluated by “Liver damage” of Liver Cancer Study Group of Japan and Child–Pugh classification in patients with hepatocellular carcinoma. Hepatol Res. 2006;34:266–72.PubMedCrossRef
13.
go back to reference Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12:1049–61.PubMedCrossRef Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl. 2006;12:1049–61.PubMedCrossRef
14.
go back to reference Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int. 2008;28:606–13.PubMedCrossRef Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int. 2008;28:606–13.PubMedCrossRef
15.
go back to reference Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, et al. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Liver Transpl. 2008;14:837–44.PubMedCrossRef Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, et al. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Liver Transpl. 2008;14:837–44.PubMedCrossRef
16.
go back to reference Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16–22.PubMedCrossRef Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16–22.PubMedCrossRef
17.
go back to reference Morris-Stiff G, Gomez D, Prasad R. Quantitative assessment of hepatic function and its relevance to the liver surgeon. J Gastrointest Surg. 2009;13:374–85.PubMedCrossRef Morris-Stiff G, Gomez D, Prasad R. Quantitative assessment of hepatic function and its relevance to the liver surgeon. J Gastrointest Surg. 2009;13:374–85.PubMedCrossRef
18.
go back to reference Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int. 2009;8:46–9.PubMed Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int. 2009;8:46–9.PubMed
19.
go back to reference Oellerich M, Armstrong VW. The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit. 2001;23:81–92.PubMedCrossRef Oellerich M, Armstrong VW. The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit. 2001;23:81–92.PubMedCrossRef
20.
go back to reference Reichen J. MEGX test in hepatology: the long-sought ultimate quantitative liver function test? J Hepatol. 1993;19:4–7.PubMedCrossRef Reichen J. MEGX test in hepatology: the long-sought ultimate quantitative liver function test? J Hepatol. 1993;19:4–7.PubMedCrossRef
21.
go back to reference Ranek L, Andreasen PB, Tygstrup N. Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut. 1976;17:959–64.PubMedCrossRef Ranek L, Andreasen PB, Tygstrup N. Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut. 1976;17:959–64.PubMedCrossRef
22.
go back to reference Afolabi P, Wright M, Wootton SA, Jackson AA. Clinical utility of (13)C-liver-function breath tests for assessment of hepatic function. Dig Dis Sci. 2012 [Epub ahead of print]. doi:10.1007/s10620-012-2340-z. Afolabi P, Wright M, Wootton SA, Jackson AA. Clinical utility of (13)C-liver-function breath tests for assessment of hepatic function. Dig Dis Sci. 2012 [Epub ahead of print]. doi:10.​1007/​s10620-012-2340-z.
23.
go back to reference Devoto G, Gallo F, Marchello C, Racchi O, Garbarini R, Bonassi S, et al. Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients. Clin Chem. 2006;52:2281–5.PubMedCrossRef Devoto G, Gallo F, Marchello C, Racchi O, Garbarini R, Bonassi S, et al. Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients. Clin Chem. 2006;52:2281–5.PubMedCrossRef
24.
go back to reference Mizuguchi T, Kawamoto M, Meguro M, Nakamura Y, Harada K, Kukita K, et al. Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy. J Gastrointest Surg. 2011;15:1433–9.PubMedCrossRef Mizuguchi T, Kawamoto M, Meguro M, Nakamura Y, Harada K, Kukita K, et al. Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy. J Gastrointest Surg. 2011;15:1433–9.PubMedCrossRef
26.
go back to reference Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev. 1989;10:308–16.PubMedCrossRef Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev. 1989;10:308–16.PubMedCrossRef
27.
go back to reference Monroe P, Vlahcevic ZR, Swell L. In vivo evaluation of lipoprotein cholesterol ester metabolism in patients with liver disease. Gastroenterology. 1983;85:820–9.PubMed Monroe P, Vlahcevic ZR, Swell L. In vivo evaluation of lipoprotein cholesterol ester metabolism in patients with liver disease. Gastroenterology. 1983;85:820–9.PubMed
28.
go back to reference Duhamel G, Nalpas B, Goldstein S, Laplaud PM, Berthelot P, Chapman MJ. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury. Hepatology. 1984;4:577–85.PubMedCrossRef Duhamel G, Nalpas B, Goldstein S, Laplaud PM, Berthelot P, Chapman MJ. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury. Hepatology. 1984;4:577–85.PubMedCrossRef
29.
go back to reference Katsuramaki T, Hirata K, Kimura Y, Nagayama M, Meguro M, Kimura H, et al. Changes in serum levels of apolipoprotein A-1 as an indicator of protein metabolism after hepatectomy. Wound Repair Regen. 2002;10:77–82.PubMedCrossRef Katsuramaki T, Hirata K, Kimura Y, Nagayama M, Meguro M, Kimura H, et al. Changes in serum levels of apolipoprotein A-1 as an indicator of protein metabolism after hepatectomy. Wound Repair Regen. 2002;10:77–82.PubMedCrossRef
30.
go back to reference Kawamoto M, Mizuguchi T, Nagayama M, Nobuoka T, Kawasaki H, Sato T, et al. Serum lipid and lipoprotein alterations represent recovery of liver function after hepatectomy. Liver Int. 2006;26:203–10.PubMedCrossRef Kawamoto M, Mizuguchi T, Nagayama M, Nobuoka T, Kawasaki H, Sato T, et al. Serum lipid and lipoprotein alterations represent recovery of liver function after hepatectomy. Liver Int. 2006;26:203–10.PubMedCrossRef
31.
go back to reference Castelino DJ, Salem HH. Natural anticoagulants and the liver. J Gastroenterol Hepatol. 1997;12:77–83.PubMedCrossRef Castelino DJ, Salem HH. Natural anticoagulants and the liver. J Gastroenterol Hepatol. 1997;12:77–83.PubMedCrossRef
32.
go back to reference Mannucci L, Dioguardi N, Del Ninno E, Mannucci PM. Value of normotest and antithrombin 3 in the assessment of liver function. Scand J Gastroenterol Suppl. 1973;19:103–7.PubMed Mannucci L, Dioguardi N, Del Ninno E, Mannucci PM. Value of normotest and antithrombin 3 in the assessment of liver function. Scand J Gastroenterol Suppl. 1973;19:103–7.PubMed
33.
go back to reference Rodzynek JJ, Preux C, Leautaud P, Abramovici J, Di Paolo A, Delcourt AA. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease. Arch Intern Med. 1986;146:677–80.PubMedCrossRef Rodzynek JJ, Preux C, Leautaud P, Abramovici J, Di Paolo A, Delcourt AA. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease. Arch Intern Med. 1986;146:677–80.PubMedCrossRef
34.
go back to reference Mizuguchi T, Kawamoto M, Meguro M, Son S, Nakamura Y, Harada K, et al. Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients. Hepatogastroenterology. 2012;59:551–7.PubMed Mizuguchi T, Kawamoto M, Meguro M, Son S, Nakamura Y, Harada K, et al. Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients. Hepatogastroenterology. 2012;59:551–7.PubMed
35.
go back to reference Iwako H, Tashiro H, Amano H, Tanimoto Y, Oshita A, Kobayashi T, et al. Prognostic significance of antithrombin III levels for outcomes in patients with hepatocellular carcinoma after curative hepatectomy. Ann Surg Oncol. 2012;9:2888–96.CrossRef Iwako H, Tashiro H, Amano H, Tanimoto Y, Oshita A, Kobayashi T, et al. Prognostic significance of antithrombin III levels for outcomes in patients with hepatocellular carcinoma after curative hepatectomy. Ann Surg Oncol. 2012;9:2888–96.CrossRef
36.
go back to reference Azuma Y, Maekawa M, Kuwabara Y, Nakajima T, Taniguchi K, Kanno T. Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness. Clin Chem. 1989;35:1399–403.PubMed Azuma Y, Maekawa M, Kuwabara Y, Nakajima T, Taniguchi K, Kanno T. Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness. Clin Chem. 1989;35:1399–403.PubMed
37.
go back to reference Niguma T, Yumura M, Yamasita Y, Maeda K, Kimura T, Yamamura M, et al. Ratio of branched chain amino acid to tyrosine after hepatectomy. Surg Today. 1999;29:825–7.PubMedCrossRef Niguma T, Yumura M, Yamasita Y, Maeda K, Kimura T, Yamamura M, et al. Ratio of branched chain amino acid to tyrosine after hepatectomy. Surg Today. 1999;29:825–7.PubMedCrossRef
38.
go back to reference Gressner AM, Gao CF, Gressner OA. Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey. World J Gastroenterol. 2009;15:2433–40.PubMedCrossRef Gressner AM, Gao CF, Gressner OA. Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey. World J Gastroenterol. 2009;15:2433–40.PubMedCrossRef
39.
go back to reference Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142(1293–1302):e1294. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142(1293–1302):e1294.
40.
go back to reference Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–26.PubMedCrossRef Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–26.PubMedCrossRef
41.
go back to reference Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726–36.PubMedCrossRef Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726–36.PubMedCrossRef
42.
go back to reference Laurent TC, Dahl IM, Dahl LB, Engstrom-Laurent A, Eriksson S, Fraser JR, et al. The catabolic fate of hyaluronic acid. Connect Tissue Res. 1986;15:33–41.PubMedCrossRef Laurent TC, Dahl IM, Dahl LB, Engstrom-Laurent A, Eriksson S, Fraser JR, et al. The catabolic fate of hyaluronic acid. Connect Tissue Res. 1986;15:33–41.PubMedCrossRef
43.
go back to reference Oh S, Afdhal NH. Hepatic fibrosis: are any of the serum markers useful? Curr Gastroenterol Rep. 2001;3:12–8.PubMedCrossRef Oh S, Afdhal NH. Hepatic fibrosis: are any of the serum markers useful? Curr Gastroenterol Rep. 2001;3:12–8.PubMedCrossRef
44.
go back to reference McGary CT, Raja RH, Weigel PH. Endocytosis of hyaluronic acid by rat liver endothelial cells. Evidence for receptor recycling. Biochem J. 1989;257:875–84.PubMed McGary CT, Raja RH, Weigel PH. Endocytosis of hyaluronic acid by rat liver endothelial cells. Evidence for receptor recycling. Biochem J. 1989;257:875–84.PubMed
45.
go back to reference Tamaki S, Ueno T, Torimura T, Sata M, Tanikawa K. Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis. Gastroenterology. 1996;111:1049–57.PubMedCrossRef Tamaki S, Ueno T, Torimura T, Sata M, Tanikawa K. Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis. Gastroenterology. 1996;111:1049–57.PubMedCrossRef
46.
go back to reference Engstrom-Laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology. 1985;5:638–42.PubMedCrossRef Engstrom-Laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology. 1985;5:638–42.PubMedCrossRef
47.
go back to reference Mizuguchi T, Katsuramaki T, Nobuoka T, Kawamoto M, Oshima H, Kawasaki H, et al. Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg. 2004;28:971–6.PubMedCrossRef Mizuguchi T, Katsuramaki T, Nobuoka T, Kawamoto M, Oshima H, Kawasaki H, et al. Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg. 2004;28:971–6.PubMedCrossRef
48.
go back to reference Kokudo N, Vera DR, Tada K, Koizumi M, Seki M, Matsubara T, et al. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg. 2002;26:1342–7.PubMedCrossRef Kokudo N, Vera DR, Tada K, Koizumi M, Seki M, Matsubara T, et al. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg. 2002;26:1342–7.PubMedCrossRef
49.
go back to reference Kaibori M, Ha-Kawa SK, Maehara M, Ishizaki M, Matsui K, Sawada S, et al. Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med. 2011;25:593–602.PubMedCrossRef Kaibori M, Ha-Kawa SK, Maehara M, Ishizaki M, Matsui K, Sawada S, et al. Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med. 2011;25:593–602.PubMedCrossRef
50.
go back to reference Harada K, Mizuguchi T, Katagiri Y, Kawamoto M, Nakamura Y, Meguro M, et al. Area between the hepatic and heart curves of (99m)Tc-galactosyl-human serum albumin scintigraphy represents liver function and disease progression for preoperative evaluation in hepatocellular carcinoma patients. J Hepatobiliary Pancreat Sci. 2011 [Epub ahead of print]. doi:10.1007/s00534-011-0486-2. Harada K, Mizuguchi T, Katagiri Y, Kawamoto M, Nakamura Y, Meguro M, et al. Area between the hepatic and heart curves of (99m)Tc-galactosyl-human serum albumin scintigraphy represents liver function and disease progression for preoperative evaluation in hepatocellular carcinoma patients. J Hepatobiliary Pancreat Sci. 2011 [Epub ahead of print]. doi:10.​1007/​s00534-011-0486-2.
51.
go back to reference Sugahara K, Togashi H, Takahashi K, Onodera Y, Sanjo M, Misawa K, et al. Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using Tc-GSA SPECT. Hepatology. 2003;38:1401–9.PubMed Sugahara K, Togashi H, Takahashi K, Onodera Y, Sanjo M, Misawa K, et al. Separate analysis of asialoglycoprotein receptors in the right and left hepatic lobes using Tc-GSA SPECT. Hepatology. 2003;38:1401–9.PubMed
52.
go back to reference Bennink RJ, Dinant S, Erdogan D, Heijnen BH, Straatsburg IH, van Vliet AK, et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med. 2004;45:965–71.PubMed Bennink RJ, Dinant S, Erdogan D, Heijnen BH, Straatsburg IH, van Vliet AK, et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med. 2004;45:965–71.PubMed
53.
go back to reference Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–13.PubMedCrossRef Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–13.PubMedCrossRef
54.
go back to reference Kawamoto M, Mizuguchi T, Katsuramaki T, Nagayama M, Oshima H, Kawasaki H, et al. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol. 2006;12:4325–30.PubMed Kawamoto M, Mizuguchi T, Katsuramaki T, Nagayama M, Oshima H, Kawasaki H, et al. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol. 2006;12:4325–30.PubMed
55.
go back to reference Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298–304.PubMedCrossRef Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298–304.PubMedCrossRef
56.
go back to reference Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12:289–99.PubMedCentralPubMed Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12:289–99.PubMedCentralPubMed
57.
go back to reference Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317–21.PubMedCrossRef Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317–21.PubMedCrossRef
58.
go back to reference Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10:S39–45.PubMedCrossRef Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10:S39–45.PubMedCrossRef
61.
go back to reference Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, Omata M, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery. 2008;143:469–75.PubMedCrossRef Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, Omata M, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery. 2008;143:469–75.PubMedCrossRef
62.
go back to reference Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, et al. Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function. Dig Dis Sci. 2012;57:1942–8.PubMedCrossRef Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, et al. Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function. Dig Dis Sci. 2012;57:1942–8.PubMedCrossRef
Metadata
Title
Preoperative liver function assessments to estimate the prognosis and safety of liver resections
Authors
Toru Mizuguchi
Masaki Kawamoto
Makoto Meguro
Thomas T. Hui
Koichi Hirata
Publication date
01-01-2014
Publisher
Springer Japan
Published in
Surgery Today / Issue 1/2014
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-013-0534-4

Other articles of this Issue 1/2014

Surgery Today 1/2014 Go to the issue